tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Eton Pharmaceuticals Inc

ETON
Add to Watchlist
46.420USD
-2.610-5.32%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.27BMarket Cap
LossP/E TTM

Eton Pharmaceuticals Inc

46.420
-2.610-5.32%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ETON Financials

See Eton Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Eton Pharmaceuticals Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
0.06/0.09
Revenue / Forecast
24.27M/22.31M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
79.95M
104.94%
EPS(YoY)
-0.17
-15.82%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
197.40%0.06
340.43%0.06
-395.95%-0.07
18.52%-0.10
-85.74%-0.06
73.89%-0.02
207.55%0.02
-166.23%-0.12
69.79%-0.03
-343.92%-0.09
---0.02
--0.18
---0.10
--0.04
----
----
----
----
----
----
Revenue
40.41%24.27M
82.72%21.28M
117.54%22.46M
108.60%18.93M
116.95%17.28M
59.26%11.65M
46.90%10.32M
-24.36%9.07M
50.19%7.97M
-13.94%7.31M
118.33%7.03M
63.05%12.00M
143.75%5.30M
39.47%8.50M
315.35%3.22M
139.91%7.36M
-81.71%2.18M
7422.22%6.09M
581.37%775.00K
15235.00%3.07M
Net Profit
198.85%1.55M
347.99%1.48M
-407.34%-1.93M
15.00%-2.58M
-93.83%-1.57M
73.49%-598.00K
208.29%627.00K
-166.70%-3.04M
69.51%-811.00K
-347.37%-2.26M
80.99%-579.00K
392.62%4.56M
50.09%-2.66M
-12.22%912.00K
50.03%-3.04M
22.72%-1.56M
-204.18%-5.33M
113.52%1.04M
6.30%-6.09M
57.38%-2.02M
Net Margin
170.40%6.40%
235.73%6.97%
-241.28%-8.58%
59.25%-13.66%
10.65%-9.10%
83.36%-5.13%
173.72%6.07%
-188.19%-33.51%
79.70%-10.18%
-387.45%-30.85%
---8.24%
--38.00%
---50.15%
--10.73%
----
----
----
----
----
----
Gross Margin
6.42%60.72%
10.71%61.56%
-42.70%34.97%
1.61%63.00%
-9.22%57.06%
12.02%55.60%
-2.57%61.04%
-23.17%62.00%
-0.36%62.85%
-33.68%49.64%
--62.65%
--80.70%
--63.08%
--74.84%
----
----
----
----
----
----
Debt to assets ratio
-11.83%31.47%
-15.29%33.17%
152.46%29.06%
102.77%29.68%
118.94%35.69%
131.04%39.16%
-36.75%11.51%
-25.69%14.64%
-39.49%16.30%
-33.88%16.95%
--18.20%
--19.70%
--26.94%
--25.64%
----
----
----
----
----
----
Income Statement
Revenue
40.41%24.27M
82.72%21.28M
117.54%22.46M
108.60%18.93M
116.95%17.28M
59.26%11.65M
46.90%10.32M
-24.36%9.07M
50.19%7.97M
-13.94%7.31M
118.33%7.03M
63.05%12.00M
143.75%5.30M
39.47%8.50M
315.35%3.22M
139.91%7.36M
-81.71%2.18M
7422.22%6.09M
581.37%775.00K
15235.00%3.07M
Operating profit
613.62%2.41M
136.02%2.46M
-369.16%-1.37M
49.74%-1.48M
41.25%-470.00K
152.38%1.04M
192.88%509.00K
-175.59%-2.94M
68.43%-800.00K
-287.66%-1.99M
81.07%-548.00K
389.78%3.88M
50.19%-2.53M
-19.18%1.06M
50.49%-2.90M
42.37%-1.34M
-194.85%-5.09M
117.71%1.31M
6.78%-5.85M
48.77%-2.33M
Net Profit
198.85%1.55M
347.99%1.48M
-407.34%-1.93M
15.00%-2.58M
-93.83%-1.57M
73.49%-598.00K
208.29%627.00K
-166.70%-3.04M
69.51%-811.00K
-347.37%-2.26M
80.99%-579.00K
392.62%4.56M
50.09%-2.66M
-12.22%912.00K
50.03%-3.04M
22.72%-1.56M
-204.18%-5.33M
113.52%1.04M
6.30%-6.09M
57.38%-2.02M
Balance Sheet
Current assets
6.58%53.24M
47.68%60.58M
142.02%72.00M
169.10%68.44M
105.91%49.96M
52.84%41.02M
9.54%29.75M
-3.41%25.43M
26.91%24.26M
34.17%26.84M
65.39%27.16M
33.16%26.33M
1.96%19.12M
-15.25%20.00M
-36.51%16.42M
-31.98%19.78M
-38.06%18.75M
-4.44%23.60M
164.31%25.86M
126.74%29.07M
Total current liabilities
74.28%44.18M
92.96%38.49M
123.89%44.18M
111.88%38.60M
65.69%25.35M
22.82%19.95M
89.88%19.73M
89.99%18.22M
104.16%15.30M
151.37%16.24M
122.98%10.39M
151.52%9.59M
115.22%7.49M
41.75%6.46M
-13.04%4.66M
22.73%3.81M
8.85%3.48M
20.14%4.56M
66.51%5.36M
13.40%3.11M
Total assets
16.28%97.71M
21.01%92.11M
191.59%104.51M
219.50%101.68M
172.88%84.03M
139.83%76.12M
13.69%35.84M
2.88%31.82M
28.69%30.79M
26.81%31.74M
46.50%31.53M
34.22%30.93M
3.16%23.93M
-8.87%25.03M
-19.12%21.52M
-22.94%23.05M
-25.62%23.20M
4.35%27.46M
133.49%26.61M
105.41%29.91M
Total liabilities
12.61%67.09M
27.59%65.96M
309.79%81.38M
323.26%77.72M
289.42%59.58M
217.87%51.70M
35.71%19.86M
29.24%18.36M
20.60%15.30M
36.07%16.26M
41.54%14.63M
44.91%14.21M
29.29%12.69M
21.53%11.95M
-5.55%10.34M
6.91%9.80M
1.89%9.81M
-7.70%9.84M
9.38%10.95M
21.81%9.17M
Total equity
25.21%30.61M
7.07%26.15M
44.71%23.13M
77.99%23.96M
57.80%24.45M
57.83%24.43M
-5.39%15.98M
-19.51%13.46M
37.83%15.49M
18.34%15.48M
51.08%16.89M
26.30%16.73M
-16.01%11.24M
-25.82%13.08M
-28.60%11.18M
-36.14%13.24M
-37.91%13.38M
12.56%17.63M
1028.24%15.66M
194.92%20.74M
Cash Flow Statement
Net operating income
254.31%7.41M
-1409.93%-11.55M
307.38%12.03M
534.18%7.96M
184.51%2.09M
-297.67%-765.00K
238.53%2.95M
-82.33%1.25M
-59.75%-2.47M
-86.37%387.00K
151.20%872.00K
188.66%7.10M
-226.57%-1.55M
155.50%2.84M
42.27%-1.70M
766.94%2.46M
-67.08%1.22M
28.75%-5.12M
42.09%-2.95M
87.07%-369.00K
Net investment
---15.07M
99.87%-49.00K
---284.00K
--0.00
100.00%0.00
-4820.26%-38.13M
--0.00
--0.00
---1.88M
-6358.33%-775.00K
100.00%0.00
100.00%0.00
100.00%0.00
99.63%-12.00K
-99900.00%-2.00M
-209.18%-761.00K
---15.00K
-7295.45%-3.25M
0.00%-2.00K
--697.00K
Net financing
252.54%1.39M
-98.75%421.00K
100.00%0.00
100.00%0.00
204.23%394.00K
11519.05%33.57M
-4.62%-385.00K
12.20%-216.00K
-671.43%-378.00K
-396.97%-294.00K
-1151.43%-368.00K
-310.26%-246.00K
87.27%-49.00K
45.59%99.00K
124.82%35.00K
-67.59%117.00K
-473.79%-385.00K
-99.68%68.00K
-106.53%-141.00K
-54.19%361.00K

FAQs

What is the total revenue of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 79.95M, with a year-on-year change of 39.01M.

What are the current assets of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its current assets were 60.58M, with a year-on-year change of 47.68.

What are the total assets of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its total assets of Eton Pharmaceuticals Inc were 92.11M, with a year-on-year change of 21.01.

What are the total liabilities of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Eton Pharmaceuticals Inc were 65.96M, with a year-on-year change of 27.59.

What is the total equity of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its total equity of Eton Pharmaceuticals Inc was 26.15M, with a year-on-year change of 7.07.

What is the net operating income of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Eton Pharmaceuticals Inc was -263.00K, with a year-on-year change of 87.95.

What is the net investment of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its net investment of Eton Pharmaceuticals Inc was -333.00K, with a year-on-year change of 99.17.

What is the net financing of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its net financing of Eton Pharmaceuticals Inc was 815.00K, with a year-on-year change of -97.50.

What is the Earnings Per Share (EPS) of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.17, with a year-on-year change of -15.82.

What is the net income of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its net income was -4.60M, with a year-on-year change of -20.35.

What is the net margin of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -5.75, with a year-on-year change of 41.28.

What is the gross margin of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 53.46, with a year-on-year change of -10.92.

What is the debt-to-asset ratio of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 33.17, with a year-on-year change of -15.29.

What is the Return on Equity (ROE) of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -18.19, with a year-on-year change of 5.05.

What is the Return on Assets (ROA) of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -5.47, with a year-on-year change of 22.84.

What is the operating profit of Eton Pharmaceuticals Inc?

According to Eton Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -263.00K, with a year-on-year change of 87.95.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy